Spectral Instruments Imaging manufactures instruments for preclinical optical (bioluminescent, fluorescent) and X-ray imaging.
Automated microscopy and image analysis
Real-time, label free cell analysis
Nano and micro particle analysis
Accelerate to discover
Back to filter
Show all topics (10)
Related topics
Top 10 Pharma companies have chosen CYTEK for their flow cytometry facility
Jun 21, 2021
6 of Top 10 Pharma Companies (Based on total group revenues) have chosen CYTEK - full spectrum flow cytometer for their...
ACCELA Educational webinar series: IntraVital Microscopy (IVM): In Vivo Live Cell Imaging Platform
Jun 11, 2021
Intravital microscopy can visualize...
Jun 10, 2021
NanoView Biosciences has developed...
Understanding bacterial biofilms more than ever before with BioFlux kinetic shear flow system
Jun 9, 2021
Bacteria and fungi organized into...
Elevated NSD3 histone methylation activity drives squamous cell lung cancer
Jun 8, 2021
This work identifies NSD3 as a principal 8p11-12 amplicon-associated oncogenic driver in LUSC, and suggests that...
IncuCyte webinar recording: How to measure Immune Cell Killing of Tumor Cells effectively
Jun 4, 2021
Immuno-oncology (IO) has transformed cancer treatment. The number of treatments in the IO pipeline continues to...
White Paper: Immunophenotyping Rare Immune Cells with Laminar Wash AUTO System
Jun 3, 2021
The Laminar Wash (LW) AUTO system consists of a wall-less plate and a laminar flow cell washer that enable automated...
A subset of cytotoxic effector memory T cells enhances CAR T cell efficacy in a model of pancreatic
Jun 3, 2021
Tonbo Biosciences flow cytometry reagents & antibodies are manufactured with the highest quality and precision and...
A carboxymethyl dextran-based polymeric conjugate as the antigen carrier for cancer immunotherapy
Sep 18, 2018
Antigen-specific cytotoxic T lymphocytes (CTLs), which eliminate target cells bearing antigenic peptides presented by surface major histocompatibility complex (MHC) class I molecules, play a key role in cancer immunotherapy. However, the majority of tumors are not immunologically rejected since they express self-antigens which are not recognized by CTLs as foreign. To foreignize these tumors for CTL-mediated immunological rejection, it is essential to develop carriers that can effectively deliver foreign antigens to cancer cells.
Related technologies: Fluorescence, luminescence, X-ray, radiographic imaging
Get more info
Brand profile
